On March 15th, Shanghai Huihe Medical’s transcatheter tricuspid valve ring shaping system K-Clip recently received approval from the National Medical Products Administration, becoming the first domestically approved tricuspid valve cardiac intervention medical device product, filling a long-term gap in this field and marking the domestic independent research and development of cardiovascular intervention medical devices moving towards the high-end of the industry chain. What is the pricing for the first tricuspid valve approved in China? The reporter learned from the manufacturer that the pricing range of this product is between 160000 and 190000 yuan, and it will be officially launched on the internet next week. (First Financial)
Scan code to share